Predictive value of serum complement (C3) in renal allograft rejection

Area of Science:

• Nephrology
• Immunology
• Transplantation Medicine

Background:

• Kidney transplant rejection remains a significant challenge impacting long-term graft survival.
• Predictive biomarkers for acute rejection are crucial for timely intervention and improved outcomes.

Purpose of the Study:

• To evaluate the utility of serum complement component C3 (C3) concentrations in predicting long-term kidney transplant survival.
• To assess the correlation between C3 levels and acute rejection episodes post-transplantation.

Main Methods:

• Serum C3 levels were measured using radial immunodiffusion in 10 kidney transplant recipients.
• Serial blood samples were collected immediately before transplantation and twice weekly thereafter.
• Acute rejection episodes were diagnosed based on clinical signs and elevated serum creatinine.

Main Results:

• Five of fourteen acute rejection episodes were associated with a decrease in serum C3 levels.
• In one patient, C3 normalization correlated with successful rejection reversal and good long-term graft function.
• Persistent low C3 levels were observed in patients with irreversible rejection requiring nephrectomy.
• A variability measure (Si > 10) predicted rejection with over 90% of the ideal lead time.

Conclusions:

• Serial C3 determinations show promise as a predictive marker for acute kidney allograft rejection.
• Early identification of falling C3 levels may allow for timely therapeutic adjustments to prevent graft loss.
• Further studies are needed to confirm these findings in a larger patient cohort.